Doyoumoney

	Nov-25	Nov-24	Nov-23	Nov-22	Nov-21	Nov-20	Nov-19	Nov-18
Total cash and short-term investments +	592.94	609.58	287.91	309.14	295.72	281.15	37.72	39.04
Cash and cash equivalents	246.96	110.00	54.63	64.47	80.51	119.36	34.82	25.59
Short-term investments	345.98	499.59	233.28	244.67	215.21	161.79	2.90	13.45
Accounts receivable, net		1.50	0.80	1.10	6.20	11.35
Inventories				-1.10	0.00
Other current assets	13.88	8.30	6.80	9.31	9.19	5.94	1.63	1.62
Total current assets	606.82	619.39	295.50	318.45	311.12	298.43	39.35	40.65
Total non-current assets +	81.32	49.96	60.10	98.31	165.65	97.91	4.69	4.74
Property, plant and equipment, net				17.16	25.35	6.67	3.87	4.42
Goodwill
Intangible assets
Long-term investments		0.00	7.42	63.88	137.19	90.89	0.51	0.00
Other non-current assets
Total assets	688.14	669.34	355.60	416.76	476.77	396.34	44.05	45.40

Total current liabilities +	86.47	95.85	86.96	70.66	66.26	44.54	16.14	32.83
Accounts payable	11.22	11.48	6.40	5.06	6.65	3.41	1.60	1.30
Short-term debt	2.82	8.01	7.49	5.53	3.85	7.63	4.62	2.84
Current portion of long-term debt
Deferred revenue
Other current liabilities	54.85	36.76	24.94	22.30	14.52	8.25	4.93	3.12
Total non-current liabilities +	62.92	46.50	68.15	42.41	68.21	61.54	85.63	49.41
Long-term debt
Capital lease obligations	55.73	28.30	30.61	11.96	13.04	0.00
Other non-current liabilities				42.41	68.21	0.85	1.74	1.22
Total liabilities	149.39	142.35	155.11	113.06	134.47	106.07	53.57	34.05

Total stockholders' equity +	538.75	526.99	200.49	303.70	342.30	290.27	-57.71	-36.85
Common stock and paid-in capital	1,541.97	1,265.76	745.69	704.95	563.19	393.97	2.74	1.91
Retained earnings	-1,003.23	-738.77	-545.20	-401.25	-220.89	-103.70	-60.46	-38.76
Common shares outstanding	87	67	54	49	43	16	39	16

Show Quarterly Balance Sheet

	Feb-26	Nov-25	Aug-25	May-25	Feb-25	Nov-24	Aug-24	May-24	Feb-24	Nov-23	Aug-23	May-23	Feb-23	Nov-22	Aug-22	May-22	Feb-22	Nov-21	Aug-21	May-21	Feb-21	Nov-20	Aug-20	May-20	Feb-20	Nov-19	Aug-19	May-19	Feb-19
Total cash and short-term investments +	540.73	592.94	428.83	485.78	549.68	609.58	448.05	443.14	243.99	287.91	258.85	281.18	277.15	309.14	344.48	297.28	261.98	295.72	343.90	386.02	303.07	281.15	354.24	173.50	71.35	37.72	0.00	0.00	39.04
Cash and cash equivalents	71.20	246.96	78.44	84.26	75.92	110.00	99.04	116.79	49.81	54.63	42.30	58.96	33.57	64.47	47.56	41.53	78.78	80.51	147.44	188.21	126.38	119.36	265.53	159.33	56.41	34.82			-39.04
Short-term investments	469.54	345.98	350.39	401.52	473.76	499.59	349.01	326.35	194.18	233.28	216.55	222.22	243.58	244.67	296.92	255.75	183.20	215.21	196.46	197.81	176.69	161.79	88.72	14.17	14.94	2.90			78.08
Accounts receivable, net	2.40		1.70	19.00	9.10	1.50	0.80	0.60	0.80	0.80	2.00	1.00	1.20	1.10	1.10	0.70	9.10	6.20	5.20	5.68	3.98	11.35	3.86	19.59
Inventories							-0.80				0.00	-1.00	-1.20	-1.10	-1.10	-0.70	0.00	0.00	0.00
Other current assets	11.26	13.88	11.77	10.55	14.02	8.30	7.19	6.48	6.18	6.80	7.10	8.84	11.18	9.31	10.39	9.51	10.30	9.19	9.34	4.58	3.71	5.94	5.99	3.71	5.31	1.63
Total current assets	554.39	606.82	440.60	515.33	563.70	619.39	456.04	450.22	250.97	295.50	267.95	290.01	288.33	318.45	354.87	306.79	280.48	311.12	358.45	396.28	310.77	298.43	364.09	196.80	76.66	39.35			39.04
Total non-current assets +	81.74	81.32	81.87	76.23	51.34	49.96	57.56	60.81	61.71	60.10	40.25	60.61	81.83	98.31	104.47	87.52	157.24	165.65	134.63	121.70	85.89	97.91	47.79	16.47	12.13	4.69			-39.04
Property, plant and equipment, net											25.61	28.44		17.16	30.35	30.93	29.39	25.35	9.57	8.35	6.96	6.67	6.53	5.79	3.98
Goodwill
Intangible assets
Long-term investments						0.00	9.47	9.38	10.29	7.42	9.88	27.46	48.45	63.88	69.13	51.54	123.69	137.19	121.48	110.44	77.19	90.89	40.90	9.11		0.51
Other non-current assets
Total assets	636.13	688.14	522.47	591.56	615.04	669.34	513.60	511.03	312.67	355.60	308.20	350.62	370.15	416.76	459.34	394.31	437.72	476.77	493.07	517.98	396.66	396.34	411.87	213.28	88.79	44.05

Total current liabilities +	92.20	86.47	82.35	75.61	89.99	95.85	86.30	80.78	87.62	86.96	61.49	72.26	64.88	70.66	67.50	72.67	66.05	66.26	50.68	46.84	47.97	44.54	41.01	34.44	30.03	16.14
Accounts payable	10.29	11.22	8.61	5.95	8.40	11.48	3.92	2.81	5.92	6.40	2.19	4.53	5.63	5.06	6.05	6.14	6.01	6.65	3.86	5.41	4.39	3.41	3.61	4.90	2.13	1.60
Short-term debt	3.20	2.82	3.79	5.24	6.64	8.01	6.55	7.93	7.31	7.49	5.36	5.58	5.56	5.53	5.50	5.47	5.43	3.85	10.94	7.08	10.14	7.63	6.14	3.93		4.62
Current portion of long-term debt
Deferred revenue
Other current liabilities	59.95	54.85	43.96	36.10	43.03	36.76	26.92	22.55	27.89	24.94	21.87	18.08	15.30	22.34	19.57	19.71	11.37	14.52	11.53	7.68	10.51	8.25	7.10	4.16	6.51	4.89
Total non-current liabilities +	63.04	62.92	67.87	68.34	44.14	46.50	50.45	59.56	56.30	68.15	12.89	18.44	31.22	42.41	49.29	54.91	65.75	68.21	67.18	72.96	78.56	61.54	63.24	72.26	128.56	85.63
Long-term debt
Capital lease obligations	58.66	55.73	56.49	51.93	26.62	28.30	27.14	28.82	29.16	30.61	8.00	9.34	10.66	11.96	13.24	14.51	15.76	13.04
Other non-current liabilities														42.41				68.21	0.80	0.84	0.83	0.85	0.87	0.87		1.74
Total liabilities	155.24	149.39	150.22	143.95	134.13	142.35	136.74	140.34	143.93	155.11	74.38	90.70	96.10	113.06	116.79	127.57	131.80	134.47	117.86	119.80	126.53	106.07	104.25	106.69	158.59	53.57

Total stockholders' equity +	480.89	538.75	372.25	447.60	480.92	526.99	376.86	370.69	168.75	200.49	233.82	259.92	274.05	303.70	342.55	266.74	305.92	342.30	375.22	398.18	270.13	290.27	307.62	106.58	-69.80	-57.71			11.35
Common stock and paid-in capital	1,571.29	1,541.97	1,297.26	1,286.19	1,276.04	1,265.76	1,057.08	1,001.96	755.47	745.69	737.06	726.18	716.04	704.95	697.08	575.57	569.34	563.19	558.41	552.53	398.11	393.97	391.40	171.85	3.05	2.74	0.00	0.00	11.35
Retained earnings	-1,090.40	-1,003.23	-925.01	-838.58	-795.12	-738.77	-680.22	-631.26	-586.72	-545.20	-503.24	-466.26	-441.99	-401.25	-354.54	-308.83	-263.43	-220.89	-183.19	-154.36	-127.97	-103.70	-83.78	-65.27	-72.85	-60.46
Common shares outstanding	110	95	84	84	84	78	73	62	55	55	54	54	54	54	51	45	45	45	44	44	39	39	17	35	21	21	21	3	3

Balance Sheet - Nurix Therapeutics, Inc. (NRIX)

Balance Sheet - Nurix Therapeutics, Inc. (NRIX)